1. Academic Validation
  2. Sigma-1 ligands: Tic-hydantoin as a key pharmacophore

Sigma-1 ligands: Tic-hydantoin as a key pharmacophore

  • Eur J Med Chem. 2010 Jan;45(1):256-63. doi: 10.1016/j.ejmech.2009.10.004.
Marion Toussaint 1 Deborah Mousset Catherine Foulon Ulrich Jacquemard Claude Vaccher Patricia Melnyk
Affiliations

Affiliation

  • 1 UMR CNRS 8161-Université Lille Nord de France-Institut Pasteur de Lille, 1 rue du Professeur Calmette, B.P. 447, 59021 Lille cedex, France.
Abstract

Sigma-1 receptors are involved in numerous pathological dysfunctions and the synthesis of selective ligands is of interest. We identified a fused tetrahydroisoquinoline-hydantoin (Tic-hydantoin) structure with high affinity and selectivity for these receptors. We report here our efforts towards the pharmacomodulation of this substructure, the synthesis of 9 analogs with stereochemistry inversion, opening of isoquinoline ring, removal of isoquinoline nitrogen, replacement of isoquinoline by pyridine, of Tic-hydantoin moiety by quinazolinedione heterocycle. All these analogs provided a loss in the affinity for the sigma-1 receptor. The present work underlines the real importance of the Tic-hydantoin moiety for the obtainment of high affinity ligands.

Figures